A newly posted agenda for next week’s meeting of the just-appointed group of outside vaccine advisers to the US Centers for ...

Shares of Gilead Sciences (NASDAQ:GILD) reached a session high on Wednesday after the U.S. Food and Drug Administration (FDA) ...

The twice-yearly injectable drug’s potential could be compromised by the Trump administration’s dramatic cuts to ...

A federal judge has rejected a bid by compounding pharmacies to allow them to continue making copies of Novo Nordisk's ...

A new twice-yearly shot could be a "game changer" in the fight against AIDS, but experts' hopes have dimmed because of the ...

The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...

CLEVELAND, Ohio – Little Remedies Honey Cough Syrup has been recalled because of the presence of bacterium and loss of shelf ...

The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences' lenacapavir, a twice-yearly injection, for ...

RFK Jr. fired everyone on a key vaccine panel. Here’s who he replaced them with. This story was originally reported by The 19th .

For decades, pharmaceutical companies have shelled out big bucks to broadcasters to place ads between segments. But a pair of ...

Gov. Healey focused on the strengths of the Massachusetts biotech ecosystem and the state programs that support it, rather than gripe about current challenges.